Victoza contains liraglutide, a GLP-1 receptor agonist that helps regulate glucose levels by enhancing insulin release when glucose is elevated and reducing glucagon secretion.

The medicine also delays gastric emptying and can influence appetite. Its once-daily injectable format allows continuous GLP-1 receptor activity throughout treatment.

Brand: Victoza

Active Ingredient: Liraglutide

Dosage Form: Injection

Pack Size: 1 injection

Drug Class: GLP-1 receptor agonist

Route: Subcutaneous

Use at the dose and frequency prescribed by the healthcare professional.